Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Application (Cancer, Neurodegenerative Disorders), Source (Bone Marrow, Mesenchymal Stem Cells), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Growth & Trends The global autologous cell therapy market size is expected to reach USD 17.97 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand ... Read More
-
Liver Cancer Drugs
... by 2030, growing at a CAGR of 18.4% over the analysis period 2023-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$5.1 Billion ... Read More
-
T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type (Peripheral, Lymphoblastic), By Therapy (Radiotherapy, Immunotherapy, Stem Cell Transplantation), By Region, And Segment Forecasts, 2024 - 2030
... global T-cell lymphoma market size is anticipated to reach USD 3.70 billion by 2030, expanding at a CAGR of 8.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. The ... Read More
-
Cancer Cachexia
... at a CAGR of 5.6% over the analysis period 2023-2030. Progestogens Therapeutics, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Breast Biopsy Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$983.4 Million ... Read More
-
Melanoma Therapeutics
... at a CAGR of 13.8% over the analysis period 2023-2030. Cutaneous Melanoma Therapeutics, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$4.3 Billion by the end ... Read More
-
Lymphoma Therapeutics
... at a CAGR of 6.6% over the analysis period 2023-2030. Non-Hodgkin Lymphoma (NHL) Therapeutics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$20.5 Billion by the ... Read More
-
Prescription Drugs
... at a CAGR of 5.7% over the analysis period 2023-2030. Generics, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$498.0 Billion by the end of the ... Read More
-
Oncology Nutrition
... at a CAGR of 9.4% over the analysis period 2023-2030. Head & Neck Cancer Nutrition, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$609.6 Million by ... Read More
-
Asia Pacific Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032
... chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032 Asia Pacific Esoteric Testing Market is valued approximately at USD 3.53 Billion in 2023 and is ... Read More
-
Cancer Therapies
... at a CAGR of 10.4% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$112.8 Billion by the end of the ... Read More
-
Brachytherapy
... of 4.4% over the analysis period 2023-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Lung Cancer Diagnostics
... by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.3 Billion by ... Read More
-
Cancer Vaccines
... at a CAGR of 9.4% over the analysis period 2023-2030. Preventive Vaccine, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$7.6 Billion by the end of ... Read More
-
Colorectal Cancer Therapeutics
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by ... Read More
-
Bladder Cancer Therapeutics
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Transitional Cell Bladder Cancer Therapeutics, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach ... Read More
-
Cancer/Tumor Profiling Market Report by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In-Situ Hybridization (ISH), Microarray, and Others), Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032
... Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032 The global cancer/tumor profiling market size reached US$ 11.5 Billion in 2023. Looking forward, IMARC Group expects the ... Read More
-
Molecular Diagnostics Market Report by Product (Reagents and Kits, Instruments, Software and Services), Technology (Polymerase Chain Reactions (PCR), Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases Diagnostics, Oncology, Genetic Testing, Blood Screening, and Others), End Users (Hospitals, Laboratories, and Others), and Region 2024-2032
... Genetic Testing, Blood Screening, and Others), End Users (Hospitals, Laboratories, and Others), and Region 2024-2032 The global molecular diagnostics market size reached US$ 19.7 Billion in 2023. Looking forward, IMARC Group expects the market to ... Read More
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
... projected to reach USD 105 million by 2029 from USD 80 million in 2024, at a CAGR of 5.5% during the forecast period of 2024 to 2029. The market is experiencing an upward trend driven ... Read More
-
Europe Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032
... reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032 Europe Esoteric Testing Market is valued approximately at USD 7.06 Billion in 2023 and is anticipated to ... Read More
-
Cancer / Tumor Profiling
... reach US$19.8 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Pancreatic Cancer Drugs
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Exocrine Drugs, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.2 Billion by ... Read More
-
Kidney Cancer Drugs
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.6 Billion by ... Read More
Research Assistance
